Prescription Drugs

Federal
US Congress 116th Congress

Protect Medicaid Act [HB-2856]
Prohibits federal payment under Medicaid for the administrative costs of providing health benefits to noncitizens who are ineligible for Medicaid based on their immigration status. The Department of Health and Human Services must report on specified information regarding states that provide health benefits to such individuals.

  

Sponsored by: Rep. Mike Johnson Referred To The Subcommittee On Health. on 05/22/2019

Weigh In

Votes for: 23 Votes against: 0

Federal
US Congress 116th Congress

Opioid Crisis Accountability Act of 2019 [S.1584]
Establishes a series of restrictions and requirements relating to opioid marketing and distribution practices. Specifically, the bill prohibits (1) knowingly making false advertising or marketing claims regarding the addictive nature of opioids; (2) knowingly supplying communities with quantities of opioids that are not medically reasonable; or (3) failing to report distribution orders, or patterns of orders, while knowing that the orders are not being dispensed in a medically reasonable manner. Employees of opioid manufacturers and distributors (continued...)

  

Sponsored by: Sen. Bernard Sanders Read Twice And Referred To The Committee On Health, Education, Labor, And Pensions. on 05/21/2019

Weigh In

No votes yet!
Cast yours now to be the first.

Votes for: 0 Votes against: 0

Federal
US Congress 116th Congress

Opioid Crisis Accountability Act of 2019 [S.1584]
Establishes a series of restrictions and requirements relating to opioid marketing and distribution practices. Specifically, the bill prohibits (1) knowingly making false advertising or marketing claims regarding the addictive nature of opioids; (2) knowingly supplying communities with quantities of opioids that are not medically reasonable; or (3) failing to report distribution orders, or patterns of orders, while knowing that the orders are not being dispensed in a medically reasonable manner. Employees of opioid manufacturers and distributors (continued...)

  

Sponsored by: Sen. Bernard Sanders Read Twice And Referred To The Committee On Health, Education, Labor, And Pensions. on 05/21/2019

Weigh In

No votes yet!
Cast yours now to be the first.

Votes for: 0 Votes against: 0

State (Alabama)
Alabama Regular Session 2019

Prescriptions, electronic prescription to specify whether a generic may be dispensed, Sec. 34-23-8 am'd. [HB-84]
Prescriptions, electronic prescription to specify whether a generic may be dispensed, Sec. 34-23-8 am'd.

  

Sponsored by: Rep. Arnold Mooney Read For The First Time And Referred To The House Of Representatives Committee On Insurance on 03/05/2019

Weigh In

No votes yet!
Cast yours now to be the first.

Votes for: 0 Votes against: 0

State (Alabama)
Alabama Regular Session 2019

Prescriptions, electronic prescription to specify whether a generic may be dispensed, Sec. 34-23-8 am'd. [HB-69]
Prescriptions, electronic prescription to specify whether a generic may be dispensed, Sec. 34-23-8 am'd.

  

Sponsored by: Rep. Arnold Mooney Delivered To Governor At 1:33 P.m. On May 29, 2019. on 05/29/2019

Weigh In

No votes yet!
Cast yours now to be the first.

Votes for: 0 Votes against: 0

Federal
US Congress 116th Congress

Pharmacy Benefit Manager Accountability Study Act of 2019 [S.1532]
A bill to require the Government Accountability Office to study the role pharmaceutical benefit managers play in the pharmaceutical supply chain and provide Congress with appropriate policy recommendations, and for other purposes.

  

Sponsored by: Sen. Marsha Blackburn Read Twice And Referred To The Committee On Health, Education, Labor, And Pensions. on 05/16/2019

Weigh In

No votes yet!
Cast yours now to be the first.

Votes for: 0 Votes against: 0

Federal
US Congress 116th Congress

Medicare Prescription Drug Fraud Prevention Act of 2019 [S.1505]
Requires prescription drug plan sponsors to report any suspicious activities relating to fraud, waste, or abuse under the Medicare prescription drug benefit and any corrective actions taken.

  

Sponsored by: Sen. Benjamin Cardin Read Twice And Referred To The Committee On Finance. on 05/16/2019

Weigh In

No votes yet!
Cast yours now to be the first.

Votes for: 0 Votes against: 0

Federal
US Congress 116th Congress

CLAY Act Creating Lower cost Alternative for Your prescription drugs Act [HB-2757]
Eliminates co-payments for generic drugs for low-income individuals who receive subsidies under the Medicare prescription drug benefit.

  

Sponsored by: Rep. Gus Bilirakis Subcommittee Hearings Held. on 05/21/2019

Weigh In

No votes yet!
Cast yours now to be the first.

Votes for: 0 Votes against: 0

Federal
US Congress 116th Congress

Health Care Price Check Act of 2019 [S.1497]
Requires Medicare, Medicare Advantage, Medicare prescription drug plan sponsors, and private health insurers to have a toll-free phone number and website through which enrollees may obtain certain health insurance information. Among other items, the phone number and website must provide information relating to cost-sharing requirements, the quality of covered items and services, and out-of-network providers, as applicable.

  

Sponsored by: Sen. Ron Wyden Read Twice And Referred To The Committee On Finance. on 05/15/2019

Weigh In

No votes yet!
Cast yours now to be the first.

Votes for: 0 Votes against: 0

Federal
US Congress 116th Congress

Lowering Prescription Drug Costs and Extending Community Health Centers and Other Public Health Priorities Act [HB-2700]
To incentivize low-cost drug options and generic competition, and to provide extensions for community health centers and the National Health Service Corps, and for other purposes.

  

Sponsored by: Rep. Steve Scalise Referred To The Subcommittee On Courts, Intellectual Property, And The Internet. on 06/26/2019

Weigh In

Votes for: 1 Votes against: 0

Federal
US Congress 116th Congress

Lowering Prescription Drug Costs and Extending Community Health Centers and Other Public Health Priorities Act [HB-2700]
To incentivize low-cost drug options and generic competition, and to provide extensions for community health centers and the National Health Service Corps, and for other purposes.

  

Sponsored by: Rep. Steve Scalise Referred To The Subcommittee On Courts, Intellectual Property, And The Internet. on 06/26/2019

Weigh In

Votes for: 1 Votes against: 0

Federal
US Congress 116th Congress

LABEL Opioids Act Lessening Addiction By Enhancing Labeling Opioids Act of 2019 [HB-2732]
Requires prescription opioids to contain a warning label specifying that the opioids may cause dependence, addiction, and overdose.

  

Sponsored by: Rep. Collin Peterson Referred To The Subcommittee On Crime, Terrorism, And Homeland Security. on 06/26/2019

Weigh In

No votes yet!
Cast yours now to be the first.

Votes for: 0 Votes against: 0

Federal
US Congress 116th Congress

LABEL Opioids Act Lessening Addiction By Enhancing Labeling Opioids Act of 2019 [S.1449]
Requires prescription opioids to contain a warning label specifying that the opioids may cause dependence, addiction, and overdose.

  

Sponsored by: Sen. Edward Markey Read Twice And Referred To The Committee On Health, Education, Labor, And Pensions. on 05/14/2019

Weigh In

No votes yet!
Cast yours now to be the first.

Votes for: 0 Votes against: 0

Federal
US Congress 116th Congress

Safer Prescribing of Controlled Substances Act [HB-2734]
Establishes a new registration requirement for a practitioner (other than a hospital, pharmacy, or veterinarian) who is licensed to dispense or conduct research with a controlled substance in schedules II, III, IV, or V of the Controlled Substances Act. Specifically, the practitioner must comply with a training requirement as a condition of obtaining or renewing their registration. The training must include information on best practices for pain management and responsible prescribing of pain medications.

  

Sponsored by: Rep. Yvette Clarke Referred To The Subcommittee On Crime, Terrorism, And Homeland Security. on 06/26/2019

Weigh In

No votes yet!
Cast yours now to be the first.

Votes for: 0 Votes against: 0

Federal
US Congress 116th Congress

Safer Prescribing of Controlled Substances Act [HB-2734]
Establishes a new registration requirement for a practitioner (other than a hospital, pharmacy, or veterinarian) who is licensed to dispense or conduct research with a controlled substance in schedules II, III, IV, or V of the Controlled Substances Act. Specifically, the practitioner must comply with a training requirement as a condition of obtaining or renewing their registration. The training must include information on best practices for pain management and responsible prescribing of pain medications.

  

Sponsored by: Rep. Yvette Clarke Referred To The Subcommittee On Crime, Terrorism, And Homeland Security. on 06/26/2019

Weigh In

No votes yet!
Cast yours now to be the first.

Votes for: 0 Votes against: 0

Federal
US Congress 116th Congress

Safer Prescribing of Controlled Substances Act [S.1448]
Establishes a new registration requirement for a practitioner (other than a hospital, pharmacy, or veterinarian) who is licensed to dispense or conduct research with a controlled substance in schedules II, III, IV, or V of the Controlled Substances Act. Specifically, the practitioner must comply with a training requirement as a condition of obtaining or renewing their registration. The training must include information on best practices for pain management and responsible prescribing of pain medications.

  

Sponsored by: Sen. Dianne Feinstein Read Twice And Referred To The Committee On Health, Education, Labor, And Pensions. on 05/14/2019

Weigh In

No votes yet!
Cast yours now to be the first.

Votes for: 0 Votes against: 0

Federal
US Congress 116th Congress

Drug-price Transparency in Communications (DTC) Act [S.1437]
Provides statutory authority for the Centers for Medicare & Medicaid Services rule titled Medicare and Medicaid Programs; Regulation to Require Drug Pricing Transparency, published on May 10, 2019. The rule requires direct-to-consumer television advertisements for covered drugs and biologics under Medicare and Medicaid to include the list price of a 30-day supply or for a typical course of treatment, if the list price is at least $35 per month. The rule takes effect July 9, 2019.

  

Sponsored by: Sen. Chuck Grassley Read Twice And Referred To The Committee On Finance. on 05/13/2019

Weigh In

No votes yet!
Cast yours now to be the first.

Votes for: 0 Votes against: 0

Federal
US Congress 116th Congress

MORE Savings Act Maximizing Opioid Recovery Emergency Savings Act [S.1424]
Modifies coverage of opioid treatments and recovery support services under Medicare, Medicaid, and private health insurance. Specifically, the bill requires the Center for Medicare and Medicaid Innovation to test a model in which specified opioid treatments and recovery support services are provided under Medicare without cost-sharing (e.g., coinsurance, copayments, and deductibles). The bill also allows state Medicaid programs to cover recovery support services as part of medication-assisted treatment (MAT) and increases the applicable Federal (continued...)

  

Sponsored by: Sen. Robert Casey Read Twice And Referred To The Committee On Finance. on 05/13/2019

Weigh In

No votes yet!
Cast yours now to be the first.

Votes for: 0 Votes against: 0

Federal
US Congress 116th Congress

An original concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2020 and setting forth the appropriate budgetary levels for fiscal years 2021 through 2024. [SCR-12]
This concurrent resolution establishes the congressional budget for the federal government for FY2020 and sets forth budgetary levels for FY2021-FY2024. The resolution recommends levels and amounts for FY2020-FY2024 for federal revenues, new budget authority, budget outlays, deficits, public debt, debt held by the public, and the major functional categories of spending. It also recommends levels and amounts for FY2020-FY2024 in the Senate for Social Security and Postal Service discretionary administrative expenses. The resolution includes reconciliation (continued...)

  

Sponsored by: Sen. Michael Enzi Committee On The Budget. Original Measure Reported To Senate By Senator Enzi. Without Written Report. (text: Cr S2127-2135) on 04/01/2019

Weigh In

Votes for: 0 Votes against: 1

Federal
US Congress 116th Congress

Affordable Prescriptions for Patients Act of 2019 [S.1416]
Prohibits patent thicketing and product hopping by drug manufacturers. In general, patent thicketing occurs when a drug manufacturer obtains new patents related to a previously-patented drug, biological product, or underlying chemical composition that extends the manufacturer’s market exclusivity for that drug without demonstrating that the new patents serve a meaningful purpose other than limiting competition from generic drug manufacturers.Product hopping is presumed when a drug manufacturer obtains removal of a drug from the Food and Drug Administration’s (continued...)

  

Sponsored by: Sen. Martha McSally Committee On The Judiciary. Reported By Senator Graham With An Amendment In The Nature Of A Substitute. Without Written Report. on 06/28/2019

Weigh In

No votes yet!
Cast yours now to be the first.

Votes for: 0 Votes against: 0